• Nenhum resultado encontrado

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

N/A
N/A
Protected

Academic year: 2016

Share "HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico"

Copied!
32
0
0

Texto

Loading

Referências

Documentos relacionados

Regarding the outcomes, patients with tuberculosis-HIV co- infection, in comparison with patients infected with tuberculosis only, had a 48% lower chance of cure, a 50% greater risk

Objective: To determine the frequency of VVC and to describe the main Candida species isolated and their susceptibility to antifun- gal drugs in HIV-infected patients, compared

In the study of a possible relationship between the TB outcome and laboratory parameters, lower mean values of hemoglobin, hematocrit, platelet and leukocytes were observed among

In the present study, we evaluated the prevalence of enteroparasitosis in tuberculosis patients, HIV-infected and non HIV infected, and we observed the influence of helminth presence

This study showed that in HIV-infected group and HIV-infected drug use group, the number of alleles whose frequency changed significantly was significantly higher than that in drug

Patients and Methods : Out of 250 deliveries from HIV-infected mothers that delivered at a tertiary public university hospital in the city of Vitória, state of Espírito

HIV positive patients in Colombia. The objectives of this study were: i) to determine the frequency of serologic evidence of HBV and HCV infection in a group of HIV infected

Objectives: To identify the frequency of subclinical atherosclerosis in HIV-infected patients compared to control subjects; to analyze associations between atherosclerosis